DrugInfoSys

Sulphadiazine

Also known as: Sulfadiazine

Drug #688

Sulphadiazine is antibecterial agent, belongs to sulphonamide. It has a broad spectrum of activity, effective against gram positive, gram negative bacteria and some protozoa.

Primary Characteristics

Sulphadiazine is also known as Sulfadiazine.

It is of Synthetic origin and belongs to Sulphonamide.

It belongs to Dihyropteroate synthetase inhibitor pharmacological group on the basis of mechanism of action and also classified in Antibacterial pharmacological group.

Molecular Weight: 250.3 · pKa: 6.4 · Solubility in Water: 1 in 13000 · Solubility in Alcohol: slight · Non-proprietary name: Sulphadiazine · pH: 9.5 · Isotonic value: 4.24.

Molecular structure of Sulphadiazine

Pharmacokinetics

Absorption: Sulphadiazine has an oral bioavailability is 100%, pre-systemic (first-pass) metabolism accounts for 25.5% (±12.5%).

Distribution: Sulphadiazine has a volume of distribution is 0.36 l/kg. plasma protein binding is 20 - 55%.

Elimination: it is metabolised via Hepatic, plasma half-life is 7 - 12 hr.

Advertisement

Indications

Sulphadiazine is primarily indicated in conditions like Chancroid, GI infections, Malaria, Nocardiosis, Pneumonia, Prevention of rheumatic fever recurrence, Respiratory tract infections, Superficial infections, Toxoplasmosis, Urinary tract infection.

Sulphadiazine is also indicated for secondary conditions like Rheumatic fever.

Contraindications

Sulphadiazine is contraindicated in conditions like Renal failure, Porphyrias, Hepatic failure, G6pd deficiency.

Dosage

Sulphadiazine's dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
0.75 g0.75 gEvery 6hPOIn Conjuction with pyrimethamine 25mg/day and with suplemental folinic acid. Doses could be given 2-4g/day in 3-6 divided doses.
Paediatric Dosage (20kg)
25 mg/kg25 mg/kgEvery 6hOralMaintenance after 2 day IV maintenance doses
37.5 mg/kg37.5 mg/kgEvery 6hOral
25 mg/kg25 mg/kgEvery 6hSlow IV Maintenance for 2 Days
50 mg/kg50 mg/kgEvery 6hSlow IV Initial
Neonatal Dosage (3kg)
25 mg/kg25 mg/kgEvery 6hOralMaintenance after 2 day IV maintenance doses
37.5 mg/kg37.5 mg/kgEvery 6hOral
25 mg/kg25 mg/kgEvery 6hSlow IV Maintenance for 2 Days
50 mg/kg50 mg/kgEvery 6hSlow IV Initial

Drug Interactions

Unknown7 interactions
2 interactions
Moderate1 interaction

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Sulphadiazine in overdosage may give rise to further complications which include Nephrotic syndrome , Serum sickness like illness , Granulocytopenia .

Sulphadiazine produces potentially life-threatening effects which include Stevens Johnson syndrome. Careful monitoring is needed with proper medical management.

The signs and symptoms that are produced after acute overdosage of Sulphadiazine are Crystalluria .

Sulphadiazine is known to cause more or less tolerable side effects which are usually transient. These include Dizziness, Headache, Nausea, Rashes , Vomiting .

Warnings / Precautions

Sulphadiazine should be used with caution in patients with liver or kidney disease, blood disorders or of any drug allergy. This may makes patients more prone to sunburn, wear protective clothing and (PABA-free) sunscreen when outdoors. It should be used only if clearly needed during pregnancy or lactation.

Interference in Pathology

Sulphadiazine may interfere in the diagnosis of Berthertol Method for estimations of Blood Urea - False Raised Results .

Available Brands

Click on a strength to view available brands.

Single Ingredient

Cream
Tabs

Multi-Ingredient Combinations

Storage Conditions

Sulphadiazine should be stored Tab, Inj.

Drug Classification

  1. 1.6.2.2.8Sulphonamides and trimethoprim

Manufacturers

Manufacturers of Sulphadiazine in Pakistan: